Cogent Biosciences, Inc. SEC filings COGT

Cogent Biosciences, Inc. has 616 filings in SEC EDGAR's recent list, going back to Oct 20, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Cogent Biosciences, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Material agreement
Sep 2, 2026 Sep 1, 2026
8-K Current report
Other events
Aug 10, 2026 Aug 10, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 9, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
8-K Current report
Other events
Dec 8, 2025 Dec 6, 2025
8-K Current report
Material agreement, New debt
Nov 18, 2025 Nov 18, 2025
8-K Current report
Material agreement, Other events
Nov 13, 2025 Nov 11, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 10, 2025 Nov 10, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
8-K Current report
Material agreement, New debt
Sep 11, 2025 Sep 5, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Material agreement, Results of operations
Jul 10, 2025 Jul 7, 2025
8-K Current report
Other events
Jul 7, 2025 Jul 7, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Jun 11, 2025 Jun 11, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Jun 5, 2025 Jun 4, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
8-K Current report
Other events
Dec 9, 2024 Dec 8, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 5, 2024 Jun 5, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Unregistered share sale, Bylaw or fiscal year change
Mar 22, 2024 Mar 21, 2024
8-K Current report
Results of operations
Feb 26, 2024 Feb 26, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
Feb 14, 2024 Feb 13, 2024
8-K Current report
Other events
Dec 11, 2023 Dec 9, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Material agreement
Jun 8, 2023 Jun 6, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2023 Jun 7, 2023
8-K Current report
Other events
Jun 6, 2023 Jun 3, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Results of operations
Mar 14, 2023 Mar 14, 2023
8-K Current report
Regulation FD disclosure
Dec 12, 2022 Dec 11, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K/A Amended current report
Material agreement, Other events
Jun 16, 2022 Jun 13, 2022
8-K Current report
Material agreement
Jun 15, 2022 Jun 13, 2022
8-K Current report
Shareholder vote results, Other events
Jun 10, 2022 Jun 7, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
8-K Current report
Agreement ended
May 6, 2022 May 5, 2022
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
8-K Current report
Officer or director change
Dec 27, 2021 Dec 24, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Results of operations
Aug 16, 2021 Aug 16, 2021
8-K Current report
Material agreement
Jul 9, 2021 Jul 6, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2021 Jun 16, 2021
8-K Current report
Results of operations
May 12, 2021 May 12, 2021
8-K Current report
Results of operations
Mar 16, 2021 Mar 16, 2021
8-K Current report
Officer or director change
Feb 22, 2021 Feb 22, 2021
8-K Current report
Material agreement, Other events
Dec 2, 2020 Dec 1, 2020
8-K Current report
Other events
Nov 30, 2020 Nov 30, 2020
8-K Current report
Results of operations, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Nov 9, 2020 Nov 6, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 26, 2020 Oct 22, 2020
8-K Current report
Officer or director change
Oct 23, 2020 Oct 19, 2020
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Oct 5, 2020 Oct 2, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Sep 3, 2020 Aug 28, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
8-K Current report
Material agreement
Aug 10, 2020 Aug 6, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Jul 6, 2020 Jul 5, 2020
8-K Current report
Shareholder vote results
Jun 10, 2020 Jun 9, 2020
8-K Current report
Officer or director change
May 15, 2020 May 14, 2020
8-K Current report
Results of operations, Other events
May 11, 2020 May 7, 2020
8-K Current report
Results of operations
Mar 26, 2020 Mar 26, 2020
8-K Current report
Material agreement, Other events
Mar 20, 2020 Mar 19, 2020
8-K Current report
Other events
Mar 16, 2020 Mar 13, 2020
8-K Current report
Shareholder vote results
Mar 10, 2020 Mar 9, 2020
8-K Current report
Other events
Mar 9, 2020 Mar 4, 2020
8-K Current report
Exit or restructuring costs, Other events
Mar 2, 2020 Mar 2, 2020
8-K Current report
Other events
Jan 29, 2020 Jan 29, 2020
8-K Current report
Agreement ended
Jan 17, 2020 Jan 16, 2020
8-K Current report
Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Listing notice
Jan 6, 2020 Dec 31, 2019
8-K Current report
Other events
Dec 9, 2019 Dec 7, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
8-K Current report
Other events
Nov 5, 2019 Nov 5, 2019
8-K Current report
Other events
Nov 4, 2019 Nov 4, 2019
8-K Current report
Results of operations
Aug 12, 2019 Aug 12, 2019
8-K Current report
Material agreement
Aug 5, 2019 Jul 31, 2019
8-K Current report
Officer or director change
Jul 29, 2019 Jul 26, 2019
8-K Current report
Officer or director change
Jul 25, 2019 Jul 19, 2019
8-K Current report
Other events
Jul 2, 2019 Jul 2, 2019
8-K Current report
Material agreement
Jun 25, 2019 Jun 21, 2019
8-K Current report
Shareholder vote results
Jun 18, 2019 Jun 18, 2019
8-K Current report
Officer or director change, Other events
Jun 14, 2019 Jun 10, 2019
8-K Current report
Results of operations
May 13, 2019 May 13, 2019
8-K Current report
Results of operations
Mar 28, 2019 Mar 28, 2019
8-K Current report
Regulation FD disclosure
Mar 7, 2019 Mar 7, 2019
8-K Current report
Material agreement
Jan 23, 2019 Jan 18, 2019
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2019 Jan 4, 2019
8-K Current report
Officer or director change, Other events
Jan 3, 2019 Jan 3, 2019
8-K Current report
Regulation FD disclosure
Dec 3, 2018 Dec 1, 2018
8-K Current report
Results of operations
Nov 13, 2018 Nov 12, 2018
8-K Current report
Results of operations, Other events
Aug 13, 2018 Aug 13, 2018
8-K Current report
Results of operations
May 14, 2018 May 14, 2018

Showing 100 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
COGT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Large accelerated filer
SEC CIK
1622229
Former names
Unum Therapeutics Inc. (until Oct 5, 2020); Unum Therapeutics, Inc. (until Mar 30, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.